Association of Industry Sponsorship With Cancer Clinical Trial Accrual

Poor accrual is the leading cause of cancer clinical trial failure, most commonly affecting late-phase trials, but the factors associated with successful accrual remain poorly understood. [1] 2][3] We therefore sought to evaluate oncologic phase 3 trials using a mandatory web-based registration database as a means of identifying and quantifying factors associated with accrual completion.